Halozyme Therapeutics
Devon Philip currently serves as the Sr. Director of Commercial Operations at Halozyme, Inc. since July 2024. Prior to this role, Devon held the position of Forecasting Lead at AstraZeneca from June 2023 to May 2024 and was the Director of Commercial Analytics at Emergent BioSolutions from December 2019 to May 2023. Additional experience includes serving as Senior Manager of Commercial Analytics at Adapt Pharma from May 2017 until its acquisition by Emergent, as well as working as a Credit Analyst at First Reserve from March 2016 to March 2017. Devon holds an MBA from The Wharton School (2022-2024) and a Master's degree in Statistics from Columbia University (2007-2008).
This person is not in any teams
This person is not in any offices
Halozyme Therapeutics
7 followers
Halozyme is a biopharmaceutical company bringing disruptive solutions to significantly improve patient experiences and outcomes for emerging and established therapies.